Science & Enterprise subscription

Follow us on Twitter

  • Then "Day at the Races" https://t.co/9VT3sNFSZG
    about 14 hours ago
  • The Forward, America’s Leading Jewish News Organization, Goes All Digital. Third-generation subscriber here and wor… https://t.co/2CdgU2WLwR
    about 15 hours ago
  • Our friends at Statista reported on a survey on how the shutdown is affecting people in the U.S., this weekend's in… https://t.co/AbSCYqzGjI
    about 19 hours ago
  • New post on Science and Enterprise: Infographic – Americans Affected by Gov’t Shutdown https://t.co/6uC0lIaMIU #Science #Business
    about 19 hours ago
  • New contributed post on Science and Enterprise: https://t.co/XjQZgoAp3S Hands Off! Robots in Modern Medicine
    about 20 hours ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Sensor-Pill System Designed for Cancer Drugs

Proteus Discover system

A system combining a tiny sensor with oral chemotherapy drugs aims to provide physicians with closer monitoring of cancer patients’ treatments and conditions. . . . → Read More: Sensor-Pill System Designed for Cancer Drugs

Cancer-Fighting Protein Designed to Cut Adverse Effects

Computational biology illustration

A computational biology lab designed a synthetic protein that works like natural cancer-fighting proteins, but in lab mice kills cancer cells with few adverse effects. . . . → Read More: Cancer-Fighting Protein Designed to Cut Adverse Effects

Start-up Funds Univ. Medical Cannabis Research

Cannabis plant

A developer of therapies derived from cannabis is sponsoring a 3-year basic and translational research program, including clinical trials, at Imperial College London. . . . → Read More: Start-up Funds Univ. Medical Cannabis Research

Lilly Buys Precision Cancer Company in $8B Deal

Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body. . . . → Read More: Lilly Buys Precision Cancer Company in $8B Deal

Trial Testing Breath Detection for Cancer

Breath collection device

A clinical trial is recruiting participants to test a technology that analyzes exhaled breath for indicators of specific types of cancer. . . . → Read More: Trial Testing Breath Detection for Cancer

Nanoscale Bacteria Particles Deliver Cancer Drugs

Salmonella typhimurium

An engineering lab developed techniques for delivering cancer drugs into tumors in lab cultures and mice with nanoscale polymer particles, aided by a strain of salmonella bacteria. . . . → Read More: Nanoscale Bacteria Particles Deliver Cancer Drugs

Post-Surgical Opioid Prescriptions Safely Cut

Pills and capsules

A cancer center reduced its opioid pain prescriptions for surgery for a year, without patients reporting more pain, complications, or requests for more pills. . . . → Read More: Post-Surgical Opioid Prescriptions Safely Cut

Report – 289 Cell and Gene Therapies in Development

Human T-cell

A report by a pharmaceutical industry organization says nearly 300 new therapies that transfer live cells or genes as treatments for disease are in clinical trials or being reviewed by Food and Drug Administration. . . . → Read More: Report – 289 Cell and Gene Therapies in Development

Self-Powered Sun Exposure Chip, App Developed

UV sensor chip

A tiny wireless sensor chip measuring exposure to ultraviolet or UV rays from the sun, developed by a university lab, is now offered by a cosmetics company with an accompanying smartphone app. . . . → Read More: Self-Powered Sun Exposure Chip, App Developed

Janssen Licensing Cancer Antibodies in $1.8B Deal

Llama

An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas. . . . → Read More: Janssen Licensing Cancer Antibodies in $1.8B Deal